|
Colloidal Silicon Dioxide
SiO2 60.08 Silica DEFINITION
Colloidal Silicon Dioxide is a submicroscopic fumed silica prepared by the vapor-phase hydrolysis of a silicon compound. When ignited at 1000
IDENTIFICATION
• A. Procedure
Analysis:
Transfer 5 mg to a platinum crucible, and mix with 200 mg of anhydrous potassium carbonate. Ignite at a red heat over a burner for 10 min, and cool. Dissolve the melt in 2 mL of freshly distilled water, warming if necessary, and slowly add 2 mL of ammonium molybdate TS to the solution.
Acceptance criteria:
A deep yellow color is produced.
• B. Procedure
[NoteAvoid contact with o-tolidine when performing this test, and conduct the test in a well-ventilated hood. ]
Analysis:
Place 1 drop of the yellow silicomolybdate solution from Identification test A on a filter paper, and evaporate the solvent. Add 1 drop of a saturated solution of o-tolidine in glacial acetic acid to reduce the silicomolybdate to molybdenum blue, and place the paper over ammonium hydroxide.
Acceptance criteria:
A greenish blue spot is produced.
ASSAY
• Procedure
Sample:
500 mg
Analysis:
Ignite the Sample in a tared platinum crucible at 1000 ± 25
Acceptance criteria:
99.0%100.5% on the previously ignited basis
IMPURITIES
Inorganic Impurities
• Loss on Ignition
• Arsenic, Method 1
Sample solution:
To 2.5 g add 50 mL of 3 N hydrochloric acid, and reflux for 30 min using a water condenser. Cool, filter with the aid of suction, and transfer the filtrate to a 100-mL volumetric flask. Wash the filter and flask with several portions of hot water, and add the washings to the flask. Cool, and dilute with water to volume.
Analysis:
A 15.0-mL portion of Sample solution, to which 3 mL of hydrochloric acid has been added, meets the requirements of the test, the addition of the 7 N sulfuric acid being omitted.
Acceptance criteria:
NMT 8 ppm
SPECIFIC TESTS
• pH
• Loss on Drying
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in well-closed containers.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 1949
Pharmacopeial Forum: Volume No. 31(4) Page 1232
|